Senate Introduces Bipartisan Legislation Aimed at Removing Cost Barriers to Prostate Cancer Screening
Lisa A. Lacasse, President at American Cancer Society Cancer Action Network shared a post by American Cancer Society Cancer Action Network on LinkedIn:
“The American Cancer Society Cancer Action Network (ACS CAN) supports the PSA Screening for HIM Act and is working with lawmakers to pass legislation at both the state and federal levels that will eliminate out-of-pocket costs for patients and improve access to prostate cancer screening tests.”
Quoting American Cancer Society Cancer Action Network‘s post:
‘The Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced this week in the Senate. This bipartisan legislation would help remove financial barriers to Prostate Cancer screening by waiving screening cost-sharing for populations with the highest risk of the disease.
Prostate cancer is the second leading cause of cancer death for men in the U.S. When the disease is detected early, the 5-year survival rate is nearly 100%. However, when the disease is detected in advanced stages, the likelihood of survival drops to just 37%.
“Out of pocket costs can be a major obstacle to accessing screening,” says Dr. Wayne Frederick, interim CEO of the American Cancer Society and ACS CAN.
The PSA Screening For HIM Act will help remove this barrier and enable those at high risk to get the prostate cancer screening tests they need to detect prostate cancer at the earliest, most treatable stage. We urge the Senate to pass this legislation to help save more lives.’
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023